This Company Wants to Rewrite the Future of Genetic Disease

This Company Wants to Rewrite the Future of Genetic Disease—Without Crispr Gene Editing

Tessera Therapeutics is developing a new class of gene editors capable of precisely plugging in long stretches of DNA—something that Crispr can’t do.
https://bit.ly/31RPFhg

The Perfect Wireless Earbuds for Every Need

Ready to cut the cord? We've tested the best buds that will never, ever get tangled. https://bit.ly/3xZfdG4

The US Finally Approved an Over-the-Counter Birth Control Pill. Here’s What to Know

By early 2024, a tablet called Opill will be sold in pharmacies without a prescription, making it easier for uninsured and young buyers to access. https://www.wired.com/story/fda-approves-over-the-counter-birth-control-pill-heres-what-to-know/?utm_source=dlvr.it&utm_medium=blogger

Face Recognition Is Being Banned—but It’s Still Everywhere

Two dozen cities and states prohibit use of the tech. But it’s on phones and is increasingly used in airports and in banks. https://bit.ly/3mCMGTf

Tech ado Labs